3656 results for «335»

Filter By

3656 results

Featured cases - Non-transfemoral TAVI access

26 Nov 2024 – From PCR London Valves 2024

Delve into this session showcasing a range of non-transfemoral TAVI access techniques from PCR London Valves 2024. Discover alternative approaches such as transiliac, transsubclavian, and transcaval access, employed to overcome complex anatomical challenges. Learn how to navigate tortuous vasculature, snare-assisted TAVR, and transform access when traditional...

Featured cases - Non-transfemoral TAVI access

Featured cases - TAVI nightmares (Part 3)

26 Nov 2024 – From PCR London Valves 2024

Brace yourself for a deep dive into TAVI nightmares from PCR London Valves 2024. Uncover cases involving severe complications such as annular ruptures, transvalvular regurgitation, instrument failures, and post-dilation balloon ruptures. Witness how skilled clinicians navigated these high-stakes scenarios and implemented life-saving interventions. Gain invaluable insights...

Featured cases - TAVI nightmares (Part 3)

Featured Research - Aortic valve (Part 8)

25 Nov 2024 – From PCR London Valves 2024

Delve into the cutting-edge research presented at PCR London Valves 2024 in this comprehensive session. Discover the latest advancements in aortic valve interventions, including AI-based predictive modeling for TAVR valve selection, insights into TAVR outcomes for bicuspid aortic valve with small annulus, the impact of prosthesis-patient...

Featured Research - Aortic valve (Part 8)

Multivalve disease: defining pathways for optimal assessment and treatment in the absence of good clinical evidence

26 Nov 2024 – From PCR London Valves 2024

Curious about managing multivalve disease in the absence of robust clinical evidence? This video is a must-watch!

You'll explore the latest strategies for assessing and treating this condition (including advanced multimodality investigations like echocardiography, magnetic resonance and cardiac catheterisation), and learn how to evaluate cardiopulmonary interactions and...

Multivalve disease: defining pathways for optimal assessment and treatment in the absence of good clinical evidence

Transcatheter tricuspid valve replacement - The fundamentals

26 Nov 2024 – From PCR London Valves 2024

Interested in learning the key steps for successful transcatheter tricuspid valve replacement?

Join this session to refine your skills in patient selection, procedural planning and execution. You'll explore a real-world case of a 62-year-old patient with heart failure symptoms and gain insights from the TRISCEND II study.

Transcatheter tricuspid valve replacement - The fundamentals

Featured research - Aortic valve (Part 10)

26 Nov 2024 – From PCR London Valves 2024

Explore the latest research and insights in the field of aortic valve interventions through this featured research session. Discover cutting-edge studies on topics ranging from one-year outcomes after TAVI in different valve types to the impact of frailty and mobility on post-TAVI outcomes, and much more....

Featured research - Aortic valve (Part 10)

Featured research - Valves and beyond

26 Nov 2024 – From PCR London Valves 2024

This session features a selection of the latest research and insights from PCR London Valves 2024, covering a wide range of topics in valvular and structural heart interventions. Discover the early results of a new TTVR system, compare the performance of different TAVI devices, explore long-term...

Featured research - Valves and beyond

Featured cases - When the cardiologist meets the surgeon

26 Nov 2024 – From PCR London Valves 2024

Dive into a collection of captivating clinical cases where the cardiologist and surgeon collaborate to tackle complex cardiovascular challenges. From direct vision TAVI implantation during left ventricular assist device surgery to managing iatrogenic annulus rupture during TAVR, this session offers invaluable insights into the art of...

Featured cases - When the cardiologist meets the surgeon

Legal notice

19 Oct 2018

Updated - August 22nd, 2023

AsiaPCR 2018: General Terms and conditions of sale

Before you register for the Course, make sure you are familiar with our General Terms and conditions of sale.

MASTER-DAPT: “the MASTER of high-bleeding risk trials”

28 Aug 2021

Marco Valgimigli (Lugano, Switzerland) presented the results of the MASTER DAPT trial on Saturday, August 28, in a Hot Line session of the ESC Congress 2021. Luis G. Ortega-Paz provides his PICOT & SWOT analysis of this study.

Luis Ortega-Paz

Author

Luis Ortega-Paz
ESC Congress 2021 - MASTER-DAPT : “the MASTER of high-bleeding risk trials”

ALL-RISE: A large-scale, global randomized trial of coronary physiology derived from conventional angiography compared with an invasive pressure wire-based approach to guide PCI

28 Mar 2026

Mirvat Al Asnag provides her take on the ALL-RISE randomised trial presented by Ajay J. Kirtane at ACC.26 in New Orleans.

Dr. Mirvat Alasnag

Author

Mirvat Alasnag
A large-scale, global randomized trial of coronary physiology derived from conventional angiography compared with an invasive pressure wire-based approach to guide percutaneous coronary intervention

Europa Group's General Terms and Conditions of Sale

12 Apr 2024

Ref 02P - Updated June 2024

Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR

29 Mar 2025

Daniele Giacoppo and Nicola Ammirabile provide their take on the main results of the HOST-BR trial, presented by Hyo-Soo Kim at ACC.25 in Chicago.

Nicola Ammirabile

Author

Nicola Ammirabile
Daniele Giacoppo

Author

Daniele Giacoppo
Harmonising optimal strategy for treatment of coronary artery diseases – bleeding risk: HOST-BR

The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation

01 Sep 2025

Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.

Author

Chiara De Biase
The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]

NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome

02 Sep 2025

Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...

Daniele Giacoppo

Author

Daniele Giacoppo
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
Didn’t find what you were looking for?